Clinical phenotypes and factor VII genotype in congenital factor VII deficiency
Autor: | Mariani, G, Herrmann, Fh, Dolce, A, Batorova, A, Etro, Daniela, Peyvandi, F, Wulff, K, Schved, Jf, Auerswald, G, Ingerslev, J, Bernardi, Francesco, INTERNATIONAL FACTOR VII DEFICIENCY STUDY GROUP |
---|---|
Rok vydání: | 2005 |
Předmět: |
Adult
Male medicine.medical_specialty Pathology Adolescent Genotype Factor VII Deficiency Hemorrhage Gene mutation Gastroenterology Asymptomatic chemistry.chemical_compound Sex Factors Polymorphism (computer science) Interquartile range Internal medicine medicine Coagulopathy Humans Expressivity (genetics) Child factor VII deficiency clinical phenotype factor VII genotype Aged Aged 80 and over Factor VII business.industry Genetic Variation Infant Hematology Middle Aged medicine.disease Phenotype chemistry Child Preschool Factor Xa Mutation Female medicine.symptom business |
Zdroj: | Mariani, G, Hermann, FH, Docle, A, Batorova, A, Etro, D, Peynandi, F, Wulff, K, Schved, JF, Auerswald, G, Ingerslev, J & Bernardi, F 2005, ' Clinical phenotypes and factor VII genotype in congenital factor VII deficiency ', Thromb. Haemost., vol. 93, pp. 481-487 . |
ISSN: | 0340-6245 |
Popis: | SummaryTo investigate the relationship between clinical phenotype, clotting activity (FVIIc) and FVII genotype, a multi-center study of factor VII (FVII) congenital deficiency with centralized genotyping and specific functional assays was carried out. FVII mutations characterized in patients (n=313) were extremely heterogeneous (103 different, 22 novel). Clinical phenotypes ranged from asymptomatic condition, including 15 homozygotes and 14 double heterozygotes, to patients with a severe disease char-acterized by life-threatening and disabling symptoms (CNS, GI bleeding and hemarthrosis) strongly associated with an early age of presentation. Based on type and number of symptoms we classified 90 'severe' (median FVIIc 1.4%, IQR [Interquartile Range] 0.9–3.8), 83 'moderate' (FVIIc 3%, IQR 1–21.7), and 140 'mild' bleeders (FVIIc 14%, IQR 3–31). The significantly different FVIIc levels, and the decreasing prevalence of homozygotes or double heterozygotes among severe (98%), moderate (84%) and mild (56%) bleeders, further support our classification. The excess of females among moderate bleeders (female/male ratio =2.6) is attributable to menorrhagia. There was no evidence for modulation of clinical features by frequent functional polymorphisms. Homozygotes for the same mutation (Ala294Val; 11125del C) with similar FVIIc and FXa generation levels, showed striking differences in clinical phenotypes. Our study depicts the ample clinical picture of this rare disorder, proposes a severity classification and provides arguments for the early management of the disease in the severe cases. Genotype-phenotype relationships indicate the presence of major environmental and/or extragenic components modulating expressivity of FVII deficiency. |
Databáze: | OpenAIRE |
Externí odkaz: |